Ralfinamide

DRUG2 trials

Sponsors

Newron Pharmaceuticals SPA

Conditions

Neuropathic PainPain

Phase 2

Phase II Dose Titration Study in Patients With Neuropathic Pain

CompletedNCT00736151

Newron Pharmaceuticals SPANeuropathic Pain

Start: 2004-05-31Updated: 2009-08-07

Phase 3

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

CompletedNCT01019824

Newron Pharmaceuticals SPAPain

Start: 2009-03-20End: 2011-08-09Updated: 2017-09-15